Crestline Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,268
Closed -$354K 218
2024
Q4
$354K Sell
13,268
-13,713
-51% -$366K 0.01% 594
2024
Q3
$720K Buy
+26,981
New +$720K 0.04% 312